← Back to Screener
NuSkin Enterprises, Inc. (NUS)
Price$7.90
Favorite Metrics
Price vs S&P 500 (26W)-31.97%
Price vs S&P 500 (4W)1.46%
Market Capitalization$380.20M
P/E Ratio (Annual)2.37x
Indicated Dividend Yield (Annual)3.14%
All Metrics
P/CF (Annual)4.74x
Book Value / Share (Quarterly)$16.71
P/TBV (Annual)0.61x
Indicated Dividend (Annual)$0.24
Revenue Growth (3Y)-12.62%
Cash Flow / Share (Quarterly)$0.95
Payout Ratio (TTM)7.39%
Price vs S&P 500 (YTD)-22.02%
Gross Margin (TTM)69.45%
Net Profit Margin (TTM)10.79%
EPS (TTM)$3.19
10-Day Avg Trading Volume0.37M
EPS Excl Extra (TTM)$3.19
Revenue Growth (5Y)-10.47%
EPS (Annual)$3.18
Dividend / Share (Annual)$0.24
ROI (Annual)15.47%
Gross Margin (Annual)69.45%
Net Profit Margin (5Y Avg)2.59%
Cash / Share (Quarterly)$4.98
P/E Basic Excl Extra (TTM)2.37x
Revenue Growth QoQ (YoY)-16.89%
EPS Growth (5Y)-2.56%
P/E Normalized (Annual)2.37x
ROA (Last FY)11.40%
Revenue Growth TTM (YoY)-14.26%
EBITD / Share (TTM)$5.79
ROE (5Y Avg)5.25%
Operating Margin (TTM)16.29%
Cash Flow / Share (Annual)$0.95
P/B Ratio0.47x
P/B Ratio (Quarterly)0.58x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.25x
Net Interest Coverage (TTM)5.67x
ROA (TTM)11.31%
EPS Growth QoQ (YoY)103.42%
EV / EBITDA (TTM)1.26x
EPS Incl Extra (Annual)$3.18
Current Ratio (Annual)2.08x
Quick Ratio (Quarterly)1.06x
3-Month Avg Trading Volume0.51M
52-Week Price Return40.82%
EV / Free Cash Flow (Annual)7.95x
P/E Incl Extra (TTM)2.37x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$15.82
P/S Ratio (Annual)0.26x
Asset Turnover (Annual)1.06x
52-Week High$14.62
Operating Margin (5Y Avg)4.73%
EPS Excl Extra (Annual)$3.18
CapEx CAGR (5Y)-11.68%
Tangible BV CAGR (5Y)-1.07%
26-Week Price Return-23.23%
Quick Ratio (Annual)1.14x
13-Week Price Return-28.31%
Total Debt / Equity (Annual)0.29x
Current Ratio (Quarterly)2.08x
Enterprise Value$365.759
Revenue / Share Growth (5Y)-9.60%
Asset Turnover (TTM)1.05x
Book Value / Share Growth (5Y)-1.00%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.46x
Pretax Margin (Annual)13.21%
Cash / Share (Annual)$5.02
3-Month Return Std Dev52.19%
Gross Margin (5Y Avg)70.64%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-3.28%
EBITDA Interim CAGR (5Y)-20.44%
ROE (Last FY)19.90%
Net Interest Coverage (Annual)5.67x
EPS Basic Excl Extra (Annual)$3.18
P/FCF (TTM)6.42x
Receivables Turnover (TTM)32.88x
EV / Free Cash Flow (TTM)7.95x
Total Debt / Equity (Quarterly)0.28x
EPS Incl Extra (TTM)$3.19
Receivables Turnover (Annual)32.88x
ROI (TTM)15.68%
Dividend Growth Rate (5Y)-30.34%
P/S Ratio (TTM)0.26x
Pretax Margin (5Y Avg)3.41%
Revenue / Share (Annual)$29.53
Tangible BV / Share (Annual)$15.82
Forward P/E7.90x
Free OCF CAGR (5Y)-31.95%
Price vs S&P 500 (52W)5.73%
P/E Ratio (TTM)2.37x
Year-to-Date Return-17.88%
5-Day Price Return5.19%
EPS Normalized (Annual)$3.18
ROA (5Y Avg)3.08%
Net Profit Margin (Annual)10.79%
Month-to-Date Return8.52%
Cash Flow / Share (TTM)$2.60
EBITD / Share (Annual)$5.78
EPS Growth (3Y)15.35%
Operating Margin (Annual)16.29%
LT Debt / Equity (Annual)0.25x
P/CF (TTM)4.74x
ROI (5Y Avg)4.31%
P/E Excl Extra (TTM)2.37x
LT Debt / Equity (Quarterly)0.25x
EPS Basic Excl Extra (TTM)$3.19
P/TBV (Quarterly)0.61x
Payout Ratio (Annual)7.39%
P/B Ratio (Annual)0.58x
Dividend / Share (TTM)$0.24
Inventory Turnover (TTM)2.46x
Pretax Margin (TTM)13.21%
Book Value / Share (Annual)$16.71
Price vs S&P 500 (13W)-31.18%
Net Margin Growth (5Y)7.81%
Dividend Yield (TTM)3.11%
Beta1.12x
P/FCF (Annual)8.26x
Revenue / Share (TTM)$29.28
ROE (TTM)20.36%
52-Week Low$5.32
Analyst Recommendations
Mar 2025
Apr 2025
May 2025
Jun 2025
2.33
2.25
2.25
2.25
Industry Peers — Drug Wholesale(8)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|
NUSNuSkin Enterprises, Inc. | 2.37x | 20.36% | 16.29% | -14.26% | $7.90 |
MCKMcKesson Corporation | 32.21x | 39.43% | 1.42% | 15.49% | $866.38 |
CORCencora, Inc. | 41.00x | 101.43% | 0.82% | 7.45% | $327.56 |
CAHCardinal Health, Inc. | 32.26x | 37.17% | 1.04% | 10.13% | $213.99 |
HLFHerbalife Ltd. | 7.71x | 170.70% | -14.76% | 0.89% | $17.02 |
COSMCosmos Holdings Inc. Common Stock | — | -74.28% | -23.86% | 6.69% | $0.41 |
WGRXWellgistics Health, Inc. Common Stock | — | -1645.88% | -414.51% | 28.73% | $0.14 |
ZSTKZeroStack Corp. Common Stock | — | -332.01% | -339.14% | — | $7.51 |
HWHHWH International Inc. Common Stock | — | -88.53% | -326.05% | -30.84% | $1.17 |
About
Nu Skin Enterprises develops and distributes beauty and wellness products globally through its Nu Skin brand and Rhyz subsidiary. The company operates across multiple geographic markets, with the Americas segment generating the majority of revenue, particularly from wellness products. Rhyz manages the company's manufacturing operations and strategic investments.